 HomeNgwaahịaAPIS na etitiCrizotinib inmemmedỌnụahịa kachasị mma API Crandotinib Post 877399-52-5-52-5-52-5-5

Ngwongwo ndi ozo

Ms. Lily

Hapụ ozi

Kpọtụrụ ugbu a

Ị nwere ike

API Cragotinib ntụ ntụ 877399-52-5-5-5 Kpọtụrụ ugbu a

Crandotinib etiti Cas enweghị 877399-73-0 Kpọtụrụ ugbu a

Pas 877399-00-3 99% Crizotinib Intentiotes Kpọtụrụ ugbu a

Ọnụahịa kachasị mma API Crandotinib Post 877399-52-5-52-5-52-5-5 Kpọtụrụ ugbu a

99% playracoutinical Crandotinib / 877399-52-5-5 Kpọtụrụ ugbu a

Enweghị M.877399-52-5 Crizotinib 99.5% Kpọtụrụ ugbu a

Pharlọ ọgwụ Cractar crandotinib Cas 877399-52-5-5-5 Kpọtụrụ ugbu a

Pharlọ Ọgwụ Cracra Craịma Star Tracratob Cas 877399-52-59% Kpọtụrụ ugbu a

 

Ọnụahịa kachasị mma API Crandotinib Post 877399-52-5-52-5-52-5-5

$5

≥1
Bag/Bags

Ụdị Ụgwọ:

L/C,T/T

Enweghi ike:

FOB,CFR,CIF

Min. Nhazi:

1 Bag/Bags

Ụgbọ njem:

Ocean,Air

Port:

Shanghai

Kpọtụrụ ugbu a

Nkọwapụta ngwaahịa

Njirimara Ngwaahịa
Tụkwasịnụ Ikike & Ozi ndị ọz�...
Nkwakọ ngwaahịa & nzipu

< >

Overview

Njirimara Ngwaahịa

Eke: DM

Tụkwasịnụ Ikike & Ozi ndị ọz�...

Nkwakọ ngwaahịa: Akpa aluminom okpukpu abụọ

Ubu oke: 100kg/month

Ụgbọ njem: Ocean,Air

Ebe Mmalite: Hetbei, China

Inye Ike: 100kg/month

Akwụkwọ: ISO9001

Port: Shanghai

Ụdị Ụgwọ: L/C,T/T

Enweghi ike: FOB,CFR,CIF

Nkwakọ ngwaahịa & nzipu

Ere Ngwa:: Bag/Bags

Agedị ngwugwu:: Akpa aluminom okpukpu abụọ

Name	Crizotinib
Other Name	PF-2341066/Crizotinib
CAS No.	877399-52-5
EINECS	N/A
MF	C21H22Cl2FN5O
MW	450.343
Purity	99% min
Usage	Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent.
Appearance	White Solid

Crizotinib (Aha Azụmaahịa Xizer) bụ ọgwụ mgbochi ọrịa cancer dị ka ALK (C-Rosphama Kintogene 1) na-ama maka ọgwụgwọ carcinoma na-abụghị obere carcinoma (NSCLC) na Anyị na ụfọdụ obodo ndị ọzọ, na-enwe ọnwụnwa na-eme nyocha na-anwale nchekwa ya na nrụpụta na ọtụtụ ndị okenye na ụmụaka.

Oru oruru

Crizotinib bụ ọgwụ mgbochi cancer dị ka ALK (Avacastic lymphoma Kinase) (NSCLC) na US na ụfọdụ mba ndị ọzọ, na Na-enyocha ọnwụnwa ọgwụ na-anwale nchekwa ya na arụmọrụ na nnukwu mkpụrụ ndụ sel lympma, na ndị ọzọ siri ike na ndị okenye ma ndị okenye.

Ngwaahịa : APIS na etiti > Crizotinib inmemmed

Ngwaahịa na-ekpo ọkụ

Email na ngwaahịa a

*Isiokwu:
*Iji:

Ms. Lily
*Email:
*Ozi:

Ozi gị ga-adị n'etiti edemede 20-8000